Protein Trial Results Suggest a Possible Treatment for COVID-19 Patients

Nurses care for a patient in an Intensive Care ward treating victims of the coronavirus disease (COVID-19) in Frimley Park Hospital in Surrey, Britain, May 22, 2020. Steve Parsons/Reuters

The preliminary trial results for a possible treatment for COVID-19 seem to suggest a possible breakthrough for one United Kingdom company, according to multiple reports.

Synairgen PLC, a biotech company from Southampton, UK, issued a statement on its website that on Monday, July 20, the company had yielded positive results from SNG001, the treatment that featured inhalation of a protein called interferon beta.